Effect of channa striata on tuberculosis in children

The effect of channa striata on tuberculosis outcome in children - effect channa striata on body mass index, Leptin level, albumin level, TNF-s, IFN-gamma in tuberculosis children

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043344

Enrollment

Registered

2021-04-10

Start date

2020-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

clinical trial on supplementary drug for tuberculosis in children

Interventions

channa striata extract for 2 month subject 2-5 years dose 2x250 mg subject 6-14 years dose 2x500 mg placebo with same form and eticket, with capsul or syrup glukosa base

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: clinical tuberculosis of lung in children 2-14 years old

Exclusion criteria

Exclusion criteria: severe tuberculosis form, include extrapulmonary TB, MDR TB severe malnutrition severe chronic disease acute infectious disease on enrollement or admission HIV positif

Design outcomes

Primary

Measure	Time frame
outcome of tuberculosis in children after 2 month suplementation of channa striata	—

Secondary

Measure	Time frame
improvement of albumin level improvement of leptin level improvement of cytokine level (TNF-a, IFN-gamma, IGF-beta) improvement of body mass index	—

Countries

Asia(except Japan)

Contacts

Public ContactMOH ANAM

lecturer at diponegoro university faculty of medicine pediatric respirology

msanam77@fk.undip.ac.id0248414296

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026